BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

558 related articles for article (PubMed ID: 11904112)

  • 1. The epidemiology of Candida glabrata and Candida albicans fungemia in immunocompromised patients with cancer.
    Bodey GP; Mardani M; Hanna HA; Boktour M; Abbas J; Girgawy E; Hachem RY; Kontoyiannis DP; Raad II
    Am J Med; 2002 Apr; 112(5):380-5. PubMed ID: 11904112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome.
    Safdar A; van Rhee F; Henslee-Downey JP; Singhal S; Mehta J
    Bone Marrow Transplant; 2001 Nov; 28(9):873-8. PubMed ID: 11781648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The changing epidemiology of invasive candidiasis: Candida glabrata and Candida krusei as the leading causes of candidemia in hematologic malignancy.
    Hachem R; Hanna H; Kontoyiannis D; Jiang Y; Raad I
    Cancer; 2008 Jun; 112(11):2493-9. PubMed ID: 18412153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Candidemia in non-neutropenic critically ill patients: analysis of prognostic factors and assessment of systemic antifungal therapy. Study Group of Fungal Infection in the ICU.
    Nolla-Salas J; Sitges-Serra A; León-Gil C; Martínez-González J; León-Regidor MA; Ibáñez-Lucía P; Torres-Rodríguez JM
    Intensive Care Med; 1997 Jan; 23(1):23-30. PubMed ID: 9037636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Candidemia: the impact of antifungal prophylaxis in a surgical intensive care unit.
    Swoboda SM; Merz WG; Lipsetta PA
    Surg Infect (Larchmt); 2003; 4(4):345-54. PubMed ID: 15012861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry.
    Horn DL; Neofytos D; Anaissie EJ; Fishman JA; Steinbach WJ; Olyaei AJ; Marr KA; Pfaller MA; Chang CH; Webster KM
    Clin Infect Dis; 2009 Jun; 48(12):1695-703. PubMed ID: 19441981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood stream infections by Candida glabrata and Candida krusei: a single-center experience.
    Choi HK; Jeong SJ; Lee HS; Chin BS; Choi SH; Han SH; Kim MS; Kim CO; Choi JY; Song YG; Kim JM
    Korean J Intern Med; 2009 Sep; 24(3):263-9. PubMed ID: 19721864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance.
    Nguyen MH; Peacock JE; Morris AJ; Tanner DC; Nguyen ML; Snydman DR; Wagener MM; Rinaldi MG; Yu VL
    Am J Med; 1996 Jun; 100(6):617-23. PubMed ID: 8678081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose fluconazole therapy for cancer patients with solid tumors and candidemia: an observational, noncomparative retrospective study.
    Torres HA; Kontoyiannis DP; Rolston KV
    Support Care Cancer; 2004 Jul; 12(7):511-6. PubMed ID: 14986077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Candida krusei fungemia. An escalating serious infection in immunocompromised patients.
    Abbas J; Bodey GP; Hanna HA; Mardani M; Girgawy E; Abi-Said D; Whimbey E; Hachem R; Raad I
    Arch Intern Med; 2000 Sep; 160(17):2659-64. PubMed ID: 10999981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Current treatment of candidemia in non-neutropenic patients. Amphotericin B or fluconazole? A retrospective study of 62 consecutive patients].
    Cobo Reinoso P; Aguado García JM; Lumbreras Bermejo C; Pérez Vela JL; Caballero Cubedo R; Sanz Sanz F; Noriega Rodríguez AR
    Rev Clin Esp; 1997 Dec; 197(12):799-803. PubMed ID: 9477669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Candidemia in women with breast carcinoma treated with high-dose chemotherapy and autologous bone marrow transplantation.
    Gottfredsson M; Vredenburgh JJ; Xu J; Schell WA; Perfect JR
    Cancer; 2003 Jul; 98(1):24-30. PubMed ID: 12833451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple-species candidemia in patients with cancer.
    Boktour MR; Kontoyiannis DP; Hanna HA; Hachem RY; Girgawy E; Bodey GP; Raad II
    Cancer; 2004 Oct; 101(8):1860-5. PubMed ID: 15386338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients.
    Pappas PG; Rex JH; Lee J; Hamill RJ; Larsen RA; Powderly W; Kauffman CA; Hyslop N; Mangino JE; Chapman S; Horowitz HW; Edwards JE; Dismukes WE;
    Clin Infect Dis; 2003 Sep; 37(5):634-43. PubMed ID: 12942393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of fluconazole prophylaxis with fungal microbiology in hospitalized intra-abdominal surgery patients: a descriptive cohort study.
    Zilberberg M; Yu HT; Chaudhari P; Emons MF; Khandelwal N; Shorr AF
    Crit Care; 2014 Oct; 18(5):590. PubMed ID: 25358521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do clinical features allow for accurate prediction of fungal pathogenesis in bloodstream infections? Potential implications of the increasing prevalence of non-albicans candidemia.
    Shorr AF; Lazarus DR; Sherner JH; Jackson WL; Morrel M; Fraser VJ; Kollef MH
    Crit Care Med; 2007 Apr; 35(4):1077-83. PubMed ID: 17312565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initial treatment and outcome of Candida glabrata versus Candida albicans bloodstream infection.
    Klevay MJ; Horn DL; Neofytos D; Pfaller MA; Diekema DJ;
    Diagn Microbiol Infect Dis; 2009 Jun; 64(2):152-7. PubMed ID: 19376667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prior antimicrobial therapy and risk for hospital-acquired Candida glabrata and Candida krusei fungemia: a case-case-control study.
    Lin MY; Carmeli Y; Zumsteg J; Flores EL; Tolentino J; Sreeramoju P; Weber SG
    Antimicrob Agents Chemother; 2005 Nov; 49(11):4555-60. PubMed ID: 16251295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for candidemia-related mortality at a medical center in central Taiwan.
    Cheng YR; Lin LC; Young TG; Liu CE; Chen CH; Tsay RW
    J Microbiol Immunol Infect; 2006 Apr; 39(2):155-61. PubMed ID: 16604249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.